SPHK1 and Alzheimer disease: The reported literature has highlighted an interesting point of similar changes in sphingolipids observed among AD, PD, HD, and ALS, and this opens new avenues to explore the Sphk1, COX2, and SPM trilogy, and N-AS signaling in other neurodegenerative disease as well.